Outlive
LongevityResearchHub

How to Study People Living Past 110: A Blueprint for Global Research

Genetic, Socioecological, and Health Research on Extreme Longevity in Semisupercentenarians and Supercentenarians: A Scoping Review.

TL;DR

This scoping review examined 144 studies on supercentenarians (people 110+) to identify what researchers currently know about extreme longevity and propose a unified international framework for studying them. The authors found that existing research is fragmented—different studies measure the same concepts using different methods and terminology—and they recommend a standardized protocol to enable more rigorous future studies.

Why This Matters

This research maps what we know about people living past 110 and proposes a shared playbook so scientists worldwide can study them consistently.

Credibility Assessment Promising — 50/100
Study Design
Rigor of the research methodology
8/20
Sample Size
Whether the study was sufficiently powered
12/20
Peer Review
Review status and journal reputation
13/20
Replication
Has this finding been independently reproduced?
5/20
Transparency
Funding disclosure and data availability
12/20
Overall
Sum of all five dimensions
50/100

What this means

This is a planning document, not a discovery. It doesn't tell us new secrets about living to 110, but it proposes a better way for scientists worldwide to coordinate their studies so future research will be more reliable. Useful for researchers, not directly actionable for individuals.

Red Flags: Publication date listed as 2026 (future) with zero citations—suggests this is a preprint, in-press manuscript, or data entry error. Journal of Aging Research is legitimate but mid-tier. No new empirical data presented; methodological framework only. Cannot assess funding conflicts from abstract alone.

Why does this matter? Supercentenarians represent living laboratories for understanding human aging at its limits. If we can identify what genetic, behavioral, social, and environmental factors allow some people to survive past 110, we might discover actionable insights applicable to the general population. However, current research on these rare individuals is scattered across many studies using incompatible methods, making it hard to draw reliable conclusions.

What did they do? The authors conducted a scoping review—a systematic map of existing literature—following established guidelines (PRISMA-ScR). They searched seven databases for peer-reviewed studies on people aged 105 and older, focusing on genetics, socioecological factors, and health outcomes. They included 144 studies and performed thematic analysis to identify common research themes.

What did they find? The analysis identified 15 key themes: age validation, demographics, behavior, personality traits, quality of life, well-being, cognition, social factors, religiosity, independence, mental health, physical health, genetics, and ecological factors. Importantly, they discovered major inconsistencies: the same concepts (e.g., "social support" vs. "social engagement" vs. "social contact") were labeled differently across studies, and assessment methods varied widely. This fragmentation makes it impossible to compare results reliably across studies.

What are the limitations? This is a scoping review, not a meta-analysis—it maps the landscape but doesn't quantitatively synthesize findings. The authors excluded unpublished data, which may miss important negative results. The paper is primarily methodological (proposing a framework) rather than reporting new empirical findings about longevity mechanisms. Citation count is zero because the paper was published in 2026 (future date, suggesting this may be a submitted manuscript awaiting indexing).

What does this mean? The paper's value lies in proposing standardization, not discovery. The authors recommend a unified international protocol with harmonized definitions, consistent measurement tools, and longitudinal design to enable larger sample sizes and more robust statistics. This is necessary groundwork for future studies but doesn't itself reveal mechanisms of extreme longevity. The framework is a blueprint, not a finding.

For longevity research, this represents an important meta-level contribution: researchers studying the world's oldest people need to agree on how to measure and compare what they're seeing. Without this, individual studies remain isolated case collections rather than building blocks of cumulative knowledge.

View Original Source

0 Comments